6.
Heichler C, Scheibe K, Schmied A, Geppert C, Schmid B, Wirtz S
. STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis. Gut. 2019; 69(7):1269-1282.
DOI: 10.1136/gutjnl-2019-319200.
View
7.
Page M, Moher D, Bossuyt P, Boutron I, Hoffmann T, Mulrow C
. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021; 372:n160.
PMC: 8005925.
DOI: 10.1136/bmj.n160.
View
8.
Widjaja A, Singh B, Adami E, Viswanathan S, Dong J, DAgostino G
. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. Gastroenterology. 2019; 157(3):777-792.e14.
DOI: 10.1053/j.gastro.2019.05.002.
View
9.
Lim W, Corden B, Ye L, Viswanathan S, Widjaja A, Xie C
. Antibody-mediated neutralization of IL11 signalling reduces ERK activation and cardiac fibrosis in a mouse model of severe pressure overload. Clin Exp Pharmacol Physiol. 2021; 48(4):605-613.
DOI: 10.1111/1440-1681.13458.
View
10.
Tang W, Yang L, Yang Y, Leng S, Elias J
. Transforming growth factor-beta stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways. J Biol Chem. 1998; 273(10):5506-13.
DOI: 10.1074/jbc.273.10.5506.
View
11.
Chen Y, Wang L, Huang S, Ke J, Wang Q, Zhou Z
. Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling. Redox Biol. 2021; 44:102020.
PMC: 8181194.
DOI: 10.1016/j.redox.2021.102020.
View
12.
Ng B, Dong J, DAgostino G, Viswanathan S, Widjaja A, Lim W
. Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis. Sci Transl Med. 2019; 11(511).
DOI: 10.1126/scitranslmed.aaw1237.
View
13.
Zhu M, Lu B, Cao Q, Wu Z, Xu Z, Li W
. IL-11 Attenuates Liver Ischemia/Reperfusion Injury (IRI) through STAT3 Signaling Pathway in Mice. PLoS One. 2015; 10(5):e0126296.
PMC: 4422694.
DOI: 10.1371/journal.pone.0126296.
View
14.
Corden B, Lim W, Song W, Chen X, Ko N, Su L
. Therapeutic Targeting of Interleukin-11 Signalling Reduces Pressure Overload-Induced Cardiac Fibrosis in Mice. J Cardiovasc Transl Res. 2020; 14(2):222-228.
DOI: 10.1007/s12265-020-10054-z.
View
15.
Sweeney M, OFee K, Villanueva-Hayes C, Rahman E, Lee M, Vanezis K
. Cardiomyocyte-Restricted Expression of IL11 Causes Cardiac Fibrosis, Inflammation, and Dysfunction. Int J Mol Sci. 2023; 24(16).
PMC: 10455677.
DOI: 10.3390/ijms241612989.
View
16.
Dong J, Viswanathan S, Adami E, Singh B, Chothani S, Ng B
. Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH. Nat Commun. 2021; 12(1):66.
PMC: 7782504.
DOI: 10.1038/s41467-020-20303-z.
View
17.
Corden B, Adami E, Sweeney M, Schafer S, Cook S
. IL-11 in cardiac and renal fibrosis: Late to the party but a central player. Br J Pharmacol. 2020; 177(8):1695-1708.
PMC: 7070163.
DOI: 10.1111/bph.15013.
View
18.
Tepler I, Elias L, Smith 2nd J, Hussein M, Rosen G, Chang A
. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood. 1996; 87(9):3607-14.
View
19.
Garbers C, Scheller J
. Interleukin-6 and interleukin-11: same same but different. Biol Chem. 2013; 394(9):1145-61.
DOI: 10.1515/hsz-2013-0166.
View
20.
Guo Y, Lu Y, Lu X, He S, Li S, Shao S
. Krüppel-Like Factor 15/Interleukin 11 Axis-Mediated Adventitial Remodeling Depends on Extracellular Signal-Regulated Kinases 1 and 2 Activation in Angiotensin II-Induced Hypertension. J Am Heart Assoc. 2021; 10(16):e020554.
PMC: 8475029.
DOI: 10.1161/JAHA.120.020554.
View